BioCryst Pharmaceuticals
BCRX
$4.16
Share price
0.00%
Change (1 day)
-45.34%
Change (1 year)
Categories
BioCryst Pharmaceuticals (BCRX) Fails to deliver data
Key failure to deliver metrics for BioCryst Pharmaceuticals :
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0.02 M
- Last 3 months FTD volume: $0.45 M
- Last year FTD volume: $1.95 M
Failures to deliver for BioCryst Pharmaceuticals (BCRX) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for BioCryst Pharmaceuticals (BCRX) - since 2013
Volume in USD (price x number of shares), data since 2013BioCryst Pharmaceuticals (BCRX) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.44 M | -83% |
| 2023 | $2.61 M | -87.57% |
| 2022 | $21.02 M | -74.17% |
| 2021 | $81.38 M | 69.16% |
| 2020 | $48.11 M | 440.33% |
| 2019 | $8.9 M | 100.99% |
| 2018 | $4.43 M | -68.51% |
| 2017 | $14.06 M | 277.58% |
| 2016 | $3.72 M | -78.39% |
| 2015 | $17.23 M | 10.36% |
| 2014 | $15.62 M | 95.45% |
| 2013 | $7.99 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Gilead Sciences GILD | $49.76 M | $0.27 B | 🇺🇸 USA |
 GlaxoSmithKline GSK | $15.53 M | $26.02 M | 🇬🇧 UK |
 Sarepta Therapeutics
SRPT | $6.44 M | $36.3 M | 🇺🇸 USA |
 Repligen
RGEN | $8.5 M | $0.10 B | 🇺🇸 USA |
 Novavax NVAX | $39.62 M | $0.34 B | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $0.8 M | $3.83 M | 🇺🇸 USA |
 NanoViricides NNVC | $0.04 M | $0.04 M | 🇺🇸 USA |
 Cel-Sci
CVM | $0.55 M | $5.02 M | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $0.74 M | $6.58 M | 🇺🇸 USA |